Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis

Gunnar Houen1, Julie Heiden1, Nicole H Trier1

  • 1Department of Autoimmunology, Statens Serum Institut, Ørestads Boulevard 5, 2300 Copenhagen S, Denmark; Department of Neurology, Rigshospitalet Glostrup, Valdemar Hansens vej 13, 2600 Glostrup, Denmark.

Insights

Expanding antibody testing for Epstein-Barr, Varicella Zoster, Measles, Mumps, and Rubella (EMMRZ) viruses improves multiple sclerosis (MS) diagnostics. This enhanced panel shows higher sensitivity for diagnosing MS and optic neuritis (ON).

Area of Science:

  • Neurology
  • Immunology
  • Virology

Background:

  • Antibody indices to Measles, Mumps, and Varicella Zoster (MRZ) viruses are established diagnostic markers for multiple sclerosis (MS).
  • The diagnostic utility of this panel may be enhanced by including additional viral antigens.

Purpose of the Study:

  • To investigate if extending the MRZ panel to include Epstein-Barr virus (EBV) and Rubella virus (RV) antigens (creating an EMMRZ panel) increases diagnostic value in multiple sclerosis (MS) and optic neuritis (ON).

Main Methods:

  • Patient samples (serum and cerebrospinal fluid - CSF) from individuals with relapsing-remitting MS (RRMS) and ON were analyzed for immunoglobulin G (IgG) reactivity against EMMRZ viral antigens.
  • Antibody indices were calculated and compared between patient groups and with the existing MRZ panel.

Main Results:

  • RRMS patients exhibited increased IgG levels in both serum and CSF against EMMRZ antigens.
  • A significant correlation was observed between serum and CSF IgG levels.
  • The EMMRZ panel demonstrated an approximate 40% increase in sensitivity compared to the MRZ panel for MS and ON diagnostics.

Conclusions:

  • The expanded EMMRZ antibody panel offers enhanced diagnostic sensitivity for multiple sclerosis (MS) and optic neuritis (ON) compared to the traditional MRZ panel.
  • This suggests the EMMRZ panel is a valuable tool for improving the diagnostic accuracy of these neurological conditions.

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...